0001035267-20-000028.txt : 20200205
0001035267-20-000028.hdr.sgml : 20200205
20200205212601
ACCESSION NUMBER: 0001035267-20-000028
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200205
FILED AS OF DATE: 20200205
DATE AS OF CHANGE: 20200205
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Johnson Amal M
CENTRAL INDEX KEY: 0001388397
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30713
FILM NUMBER: 20580680
MAIL ADDRESS:
STREET 1: C/O MELLANOX TECHNOLOGIES, INC.
STREET 2: 350 OAKMEAD PARKWAY, SUITE 100
CITY: SUNNYVALE
STATE: CA
ZIP: 94085
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC
CENTRAL INDEX KEY: 0001035267
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
IRS NUMBER: 770416458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
BUSINESS PHONE: 4085232100
MAIL ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0306
4
2020-02-05
0
0001035267
INTUITIVE SURGICAL INC
ISRG
0001388397
Johnson Amal M
1020 KIFER ROAD
SUNNYVALE
CA
94086
1
0
0
0
Common Stock
2020-02-05
4
M
0
4250
119.0633
A
13456
D
Common Stock
2020-02-05
4
S
0
4250
577.4332
D
9206
D
Non-Qualified Stock Option (right to buy)
119.0633
2020-02-05
4
M
0
4250
0.0
D
2021-04-21
Common Stock
4250
3000
D
These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 15, 2020.
The average selling price for the transaction was $577.433231. Shares sold at $574.381 - $574.951 = 500; shares sold at $575.05 - $575.79 = 1,059; shares sold at $576.40 - $576.449 = 557; shares sold at $577.958 - $578.82 = 358; shares sold at $579.09 - $579.882 = 1,495; shares sold at $580.6 - $581.36 = 281.
Non-statutory stock option granted pursuant to the Non-Employee Directors' Stock Option Plan. Option shall vest 100% one year after the date of grant or at the next Shareholders Meeting, whichever should take place first, provided that vesting will cease on termination of the Directors service to the Company.
By: Lori Serrano For: Amal M. Johnson
2020-02-05